Recent Newsletters
R.J. Hedges & Associates
Our newsletters keep you informed about current healthcare issues and regulatory changes, events, and accreditation discrepancies.
See past newsletter editions below.
2024 - Newsletters
December's Newsletter includes: PBM Lawsuit Win, GLP in Compounding, Change of Ownership, Corrective Actions and Medicare Requests, Telemedicine update
November's Newsletter includes: Pharmacy Closures, Changes to Notifications in Medicare Part B, DSCSA requirements, FDA Warning, Reimbursement issues with PBMs
October's Newsletter includes: Wholesalers increase Controlled Vigilance, PPE Tariffs, Rescinded HCPCS codes, DSCSA requirements, New DMEPOS Product Category
September's Newsletter includes: Reminders for HETS, DEA, and CMS items, Updates to Assessments of Risk, CDC-don't use LY COVID vaccines, Possible CMS delay
August's Newsletter includes: Updated Hazardous Drug Assessments of Risk, CMS DMEPOS Exemption Requirements, Mandatory Training for Prescribing Controls for Physicians
July's Newsletter includes: Role and location changes at RJH, Expanded Age for RSV, HIPAA Change, Moving Sale, DME JD Newsletter, Cost Savings for Prescriptions
June's Newsletter includes: DEA Marijuana rule change, State Verification for FWA, Preventing Claim Denials of Diabetic Shoes, Express Scripts violates Part D
May's Newsletter includes: eFraud Alert, Cyberattack update, Medicare Part B And PECOS, and general P&P/Form updates
April's Newsletter includes: Complaints to Medicare, Immunization Award, Cyber Attack, HIPAA Update, 2025 Part D Contracts, and general P&P/Form updates
March's Newsletter includes: ACHC Certification, Cyber Attack, HIPAA Update, NP East and West Applications, and general P&P/Form updates
February's Newsletter includes: Medicare Application Issues NP East, DEA Site updates, Lymphedema changes and Billing.
2025 - Newsletters
CMS updates on DMEPOS accreditation, Medicare exemptions, WAC changes, Part B billing, enforcement actions, CLIA updates, and December compliance tasks.
November pharmacy compliance update: new ACHC requirements, NSC tracking forms, Part B vaccine rules, enforcement actions, COVID-19 guidance, and credentialing reminders.
HHS issues new interoperability rule, 340B faces scrutiny, HIPAA settlement, Immunization Requirements, and key updates for pharmacies this October.
Pharmacy & DME updates: PBM lawsuits, CMS survey changes, FDA reporting, LTC at Home audits, and compliance tips
Stay informed on LTC at Home audits, compliance updates, measles surge, vaccines, 340B protections & pharmacy best practices
CMS town hall, OSHA updates, LTC at Home launch, cyberattacks, and our 1st Customer Survey—your July compliance updates in one place!
June 2025 Newsletter: CMS inspector alerts, Medicare pricing updates, measles outbreak, Rite-Aid closures, DMEPOS, Novavax news & more.
May Newsletter: Compounding GLP1 Update, Medicare and Vaccine update, Updated AoR, Medicare Accreditation Exemption
April Newsletter: HIPAA 2026 changes, AoR relaunch, roster billing updates, NGSConnex MRNs, LTC at home, FDA rulings, Optum Rx access, and key P&P changes.
Marcch's Newsletter includes: FDA updates for Testosterone and Semaglutide, LTC @ Home coming soon, Pharm Tech Immunization Training, Prime Therapeutics M3P
February's Newsletter includes: Compounding Master Formula answers, AoR update, LTC @ Home update, DMEPOS Billing, New DME Product Code, Policy Changes
January's Newsletter includes: New Year New DMEPOS items, CMS Audit Flag, Billing Apology, Update to Portal
2026 - Newsletters
FDA GLP-1 oversight, CMS DMEPOS changes, PBM enforcement, TrumpRx updates, drug supply risks, and ACHC Partnership.
Medicare and pharmacy compliance updates: CMS tools, PBM reform, FTC settlement, DSCSA warning, M3P guidance, and enforcement highlights.
HIPAA 2026 changes, Optum and M3P Compliance, Outdated IT Putting Patient Safety and Cybersecurity at Risk, Medicare Part B Billing, New Compliance Advisor
Latest Medicare and CMS updates covering DMEPOS rules, accreditation changes to BOC, audits, drug pricing, enforcement, and compliance requirements.